دورية أكاديمية
Zilucoplan (Zilbrysq) for myasthenia gravis.
العنوان: | Zilucoplan (Zilbrysq) for myasthenia gravis. |
---|---|
المصدر: | The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 Apr 15; Vol. 66 (1700), pp. 60-62. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: New Rochelle, NY : The Medical Letter |
مواضيع طبية MeSH: | Myasthenia Gravis*/diagnosis , Myasthenia Gravis*/drug therapy , Complement C5* , Peptides, Cyclic*, Humans ; Immunosuppressive Agents |
فهرسة مساهمة: | Keywords: Rystiggo; Soliris; Ultomiris; Vyvgart; Zilbrysq; adverse effects; azathioprine; dosage; eculizumab; efficacy; efgartigimod alfa; lactation; meningococcal vaccine; myasthenia gravis; mycophenolate mofetil; pregnancy; pyridostigmine; ravulizumab; rozanolixizumab; safety; zilucoplan |
المشرفين على المادة: | YG391PK0CC (zilucoplan) 0 (Immunosuppressive Agents) 0 (Complement C5) 0 (Peptides, Cyclic) |
تواريخ الأحداث: | Date Created: 20240405 Date Completed: 20240408 Latest Revision: 20240408 |
رمز التحديث: | 20240408 |
DOI: | 10.58347/tml.2024.1700c |
PMID: | 38576149 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1523-2859 |
---|---|
DOI: | 10.58347/tml.2024.1700c |